Properties
Description
Voruciclib is an CDK kinase inhibitor that disrupts cell division processes. It targets CDK1/cyc A, CDK1/cycB, CDK4/Cyc D1, and CDK6/cycD1.
Molecular Formula
C22H19ClF3NO5
Targets
CDK1/cyc A: 9.1 nM (Ki); CDK1/cycB: 5.4 nM (Ki); CDK4/Cyc D1: 3.96 nM (Ki); CDK6/cycD1: 2.92 nM (Ki)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Voruciclib can be employed to investigate the inhibition of CDK9 and its potential as a cancer therapeutic.